Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Exact Sciences to participate in September investor conferences


PR Newswire | Sep 1, 2021 06:00AM EDT

09/01 05:00 CDT

Exact Sciences to participate in September investor conferences MADISON, Wis., Sept. 1, 2021

MADISON, Wis., Sept. 1, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

* Wells Fargo Virtual Healthcare ConferenceFireside Chat on Thursday, September 9, 2021 at 10:40 a.m. EDT * Baird 2021 Global Healthcare ConferenceFireside Chat on Wednesday, September 15, 2021 at 12:15 p.m. EDT

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:Megan JonesExact Sciences Corp.meganjones@exactsciences.com608-535-8815

View original content to download multimedia: https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-september-investor-conferences-301366904.html

SOURCE EXACT SCIENCES CORP






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC